← Portfolio Scout

Portfolio company

Endogenex

United States · £39.5m raised

Raised

£39.5m

Latest stage

Growth

Rounds recorded

1

Backed by

3 investors

Sectors

Digital Health

About

This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.

Source

Funding history · 1

  1. 2026-03-25Growth$50m

Similar companies